The combination of temozolomide with an inhibitor of TDP1 (compounds 57a,b, Figure 16) lowered the viability of human glioblastoma cell lines U87MG and SNB19 by as much as 40% as compared with temozolomide alone. The gene discussed is TDP1; the disease is glioblastoma.